SK's 5-year journey toward batteries, bio and chips
Kyung-Min Kang
Jan 23, 2022 (Gmt+09:00)
Back in January 2017, SK Group Chairman Chey Tae-won emphasized the need for “deep change," in his New Year message and presented the phrase as the South Korean conglomerate's business keyword for the year.
Five years on, the domestic sales-oriented conglomerate has come a long way. It has undergone dramatic changes to transform from a group with a focus on petrochemical, chemical and telecom services into one pivoting on electric vehicle batteries, bio and chips, with eyes set on overseas markets.
As a first toward the move, the country's third-largest business group has made massive investments into the new so-called BBC businesses, an acronym for batteries, bio and chips.
Of the total of its 48 trillion won ($40 billion) spending on global businesses between 2017 and 2021, 38 trillion won, or 80%, had been funneled into the BBC sectors, according to SK Group.
The 38 trillion won was then divided into 19 trillion won for batteries; 17 trillion won for chips; and 2 trillion won for the bio sector.
BATTERIES
At the forefront of the deep change was SK Innovation Co. In 2017, the company announced massive spending plans to improve corporate value, including expanding the capacity of its battery plants and the business of battery separators, used to keep the positive and negative electrodes apart.
Once the three battery plants jointly owned by Ford are completed by 2025, SK will likely become the largest battery producer in the US with a capacity of 150.5 gigawatt-hours.
CHIPS
To beef up its NAND flash business, SK Hynix Inc., the world's second-largest memory chipmaker, acquired Toshiba Corp.'s memory chip unit in 2017 in a consortium with Bain Capital. Subsequently, it took over a local silicon wafer manufacturer, now renamed SK Siltron Co., from LG Group.
In the same year, SK Group established an artificial intelligence (AI) chip designing company SAPEON and an AI solutions developer Gauss Labs in San Jose, California. It is now working on launching a semiconductor R&D center in the US for 1.2 trillion won.
BIO
To increase its foothold in the US pharmaceutical market, the group's holding firm SK Inc. combined its pharmaceutical businesses scattered in a number of countries into SK Pharmteco Co. in 2019.
The California-based contract development and manufacturing organization is seeking a Nasdaq listing next year, its CEO Aslam Malik said in a healthcare conference hosted by JPMorgan earlier this month.
Prior to its IPO, it plans to raise between 400 billion won and 600 billion won in new funding.
NEXT FIVE YEARS
Looking ahead, Chairman Chey is trying to deepen cooperation with other South Korean business groups such as Samsung and LG to tackle global supply chain bottlenecks as "one Korean team," and further expand its share in the semiconductor and battery markets, said an SK source.
South Korea's three EV battery makers -- SK On, LG Energy Solution Ltd. and Samsung SDI Co. -- are expected to control 70% of the battery production capacity in the US by 2025, when the three companies plan to complete the construction of their new US plants.
Write to Kyung-Min Kang at kkm1026@hankyung.com Yeonhee Kim edited this article.